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ABSTRACT 
The aims of this study were (1) to compare the in vitro dissolution profiles of Solid dispersion of Cefpodoxime 
Proxetil with PEG 6000, with those of pure drug and physical mixture of Cefpodoxime proxetil and PEG 6000. (2) to 
apply statistical models to evaluate each ratio of Cefpodoxime proxetil and PEG 6000 in solid dispersion in terms of 
easy application and usefulness, and (3) to identify the most suitable ratio of Cefpodoxime Proxetil and PEG 6000 as 
solid dispersion. 
Solid  dispersions  of  Cefpodoxime  Proxetil  were  prepared  with  PEG  6000  in  different  ratios  by  using  kneading 
method. Dissolution profile of all these solid dispersions were compared with dissolution profile of  Cefpodoxime 
proxetil and physical mixture of Cefpodoxime proxetil and PEG 6000. The results showed that the Solid dispersions 
containing PEG in different proportions exhibit faster release (about 2.2 – 3 fold faster) than Cefpodoxime proxetil 
and physical mixture of Cefpodoxime proxetil and PEG. Among the solid dispersions containing different ratios 
batch A containing Cefpodoxime proxetil and PEG 6000 in 1:1 ratio exhibited about 3 fold improvement in release 
profile. The release kinetics of Solid dispersions was investigated using several mathematical equations. In Model-
independent method similarity factor, f2, was used for the comparison of in vitro dissolution profiles. The results 
showed  that  model-dependent  methods  were  more  discriminative  than  model-independent  methods.  Model 
independent methods seemed to be easier to apply and interpret; only one value is obtained to describe the closeness 
of the two dissolution profiles. The application and evaluation of model-dependent methods were  more complicated; 
these methods present an acceptable model approach to the true relationship between percent dissolved and time 
variables, including statistical assumptions that could be checked. 
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INTRODUCTION 
Cefpodoxime proxetil (CP) is a poorly water-soluble 3
rd 
generation  broad  spectrum  β-  Lactam  cephalosporin 
class of antibiotic, according to the BCS system (Class 
IV), and its dissolution is one of the rate-limiting step for 
absorption
1.  Drug  absorption  from  solid  dosage  forms 
after oral  administration depends on the release of the 
drug substance from the drug product, the dissolution or 
solubilization of the drug under physiological conditions, 
and  the  permeability  across  the  gastrointestinal  tract. 
Because of the critical nature of the first two steps, in 
vitro dissolution may be relevant to the prediction of in 
vivo performance. Based on this general consideration, 
in vitro dissolution tests for immediate-release solid oral 
dosage forms are used: to assess the lot-to-lot quality of a 
drug product, to assess the stability of the drug product, 
to  ensure  continuing  product  quality  and  performance 
after certain changes (e.g., changes  in the  formulation, 
manufacturing process, site of manufacture, and scale-up 
of  the  manufacturing  process),  to  develop  new 
formulations
2. 
In formulation development, dissolution testing can aid 
in  the  selection  of  excipients,  the  optimization  of  the 
manufacturing  process,  and  the  formulation  of  a  test 
product to match the release of the reference product
3,4. 
The  solubility,  permeability,  dissolution,  and 
pharmacokinetics of the drug substance are parameters 
used to set the dissolution method and specification. The Dhoka Madhura V et al / IJRAP 2011, 2 (2) 650-654 
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methods  for  the  comparison  of  in  vitro  dissolution 
profiles  can  be  classified  into  three  groups,  model-
dependent methods, and model-independent methods and 
methods based on analysis of variance (ANOVA)
5-7. 
The  purpose  of  the  present  work  was  to  enhance 
dissolution  rate,  by  preparing  solid  dispersions  of  CP 
using  PEG  6000  as  carrier  and  by  using  kneading 
method
8-10. The release profile of solid dispersions was 
compared with CP and physical mixture (PM) of CP and 
PEG  6000  and  among  themselves  using  model-
dependent  and  model-independent  methods.  The  most 
suitable ratio of CP and PEG 6000 to get solid dispersion 
of better dissolution profile was determined.  
MATERIALS AND METHODS 
Cefpodoxime Proxetil (CP) was obtained as a gift sample 
from  Maxim  Pharmaceutical  Pvt.  Ltd.  (Pune,  India). 
Polyethylene  Glycol  (PEG6000)  was  supplied  by 
Colorcon Asia Ltd. (Goa, India), All solvents used were 
of analytical grades and were used as obtained. 
Solid dispersions of CP with PEG 6000 were prepared in 
the ratios of 1:1, 1:0.75, 1:0.5, 0.75:1 and 0.5:1 ( Batch 
No A,B,C,D,E  respt) of CP to PEG 6000 by  using a 
kneading method. A mixture of CP and PEG 6000 (ratios 
of 1:1, 1:0.75 and 1:0.5, 0.75:1, 0.5:1 w/w) was wetted 
with methanol and kneaded thoroughly. The blend was 
dried and finally passed through # 60. The formulation 
and batch codes of all Solid dispersions are described in 
Table 1. 
Dissolution Testing 
In vitro dissolution studies of prepared solid dispersions 
were carried out in 900 mL of 0.1 N HCl as a medium 
using  USP  Apparatus  2  (paddle  method)  with  three 
replicates. The paddle rotation speed was 75 rpm, and a 
temperature of  37  ±  1  °C  was  used  in  the  test.  In  all 
experiments, 5 mL of dissolution sample was withdrawn 
at 15, 30, 45 and 60 min interval, filtered using a 0.45-
mm Whatman filter, and replaced with an equal volume 
of  fresh  medium  to  maintain  a  constant  total  volume. 
Samples were analysed by UV spectrophotometry at 263 
nm (JASCO, V-550, Japan). Cumulative percentages of 
drug dissolved from the solid dispersions were calculated 
by using pcp disso software
11. 
Methods To Compare Dissolution Profiles 
Model-Independent Methods 
For  the  determination  of  dissolution  data  equivalence, 
FDA guidance documents recommend approaches such 
as  the  model-independent  approach  based  on  the 
calculation of difference (f1) and similarity (f2) factors. 
The main advantage of the f1 and f2 equations is that 
they  provide  a  simple  way  to  compare  the  data. 
Nevertheless,  both  equations  do  not  account  for  the 
variability or correlation structure of the data, and they 
are  sensitive  to  the  number  of  points  used.  From  a 
statistical  point  of  view,  this  method  seems  to be  less 
discriminating than other methods, such as ANOVA and 
model-dependent  methods.  According  to  the  FDA 
guidance,  f1  values  of  0–15  and  f2  values  of  50–100 
ensure sameness or equivalence of the two dissolution 
profiles.  In  both  equations,  R  and  T  represent  the 
dissolution  measurements  at  P  time  points  of  the 
reference and test, respectively. Formulas for f1 and f2 
value determinations are given as per equations 1 and 2 
respectively
2,5,7,11.  
 
 
 
   
Model-Dependent Methods 
Release  kinetics  of  CP  and  its  solid  dispersions  was 
analyzed by  various  mathematical  models, which were 
applied considering the amounts of drug released from 0 
to 60 mins. Table 2 presents the various models tested. 
Depending  on  these  estimations,  suitable  mathematical 
models  to  describe  the  dissolution  profiles  were 
determined
2,11. 
The  following  plots  were  made:  cumulative  %  drug 
release  versus  time  (zero-order  kinetic  model);  log 
cumulative  %  drug  remaining  versus  time  (first-order 
kinetic model); cumulative % drug release versus square 
root  of  time  (Higuchi  model);  cube  root  of  drug  % 
remaining in matrix versus time (Hixson–Crowell cube 
root law); Log cumulative percent drug released Vs log 
time (Korsmeyer- peppas)
2,5,7. Dhoka Madhura V et al / IJRAP 2011, 2 (2) 650-654 
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RESULTS AND DISCUSSION 
The  in  vitro  dissolution  profiles  of  various  solid 
dispersions  are  shown  in  Figure1.  Each  data  point 
represents a mean of three measurements for each solid 
dispersion. All prepared solid dispersions showed more 
than 80% release in 60 min. CP and its Physical Mixture 
(PM) with PEG 6000 showed less than 80 % release in 
60 min. All Solid dispersions showed rise in % release at 
the end of 60 minutes as compared to CP and PM. This 
indicates  that  solid  dispersions  have  better  dissolution 
rate than CP and PM. Solid dispersion A showed about 
99.15% release at the end of 60 min which was highest 
among the solid dispersions A-E. Hence dissolution rate 
of  solid  dispersion  A  is  higher  than  all  other  solid 
dispersions. 
Model-Independent Methods 
The dissolution profile of pure drug CP is dissimilar to 
profiles  of  PM  and  solid  dispersions  A  -  E.  The 
cumulative % drug release of solid dispersion A was 3 
times faster, of Solid dispersion B and C was 2.5 times 
faster, and of solid dispersions D, E are about 2.2 times 
faster  than  CP.    It  indicates  that  when  drug  and  PEG 
6000 are present as 1:1 ratio in solid dispersion (as in 
solid dispersion A), maximum rise in dissolution rate is 
observed. When proportion of PEG 6000 is more than 
the  drug  in  a  solid  dispersion  (as  in  D  and  E)  rise  in 
dissolution  rate  is  less  than  when  proportion  of  PEG 
6000  is  less  than  CP.  As  proportion  of  PEG  6000 
increases  from  0.5  to  1  part,  (for  1  part  of  CP) 
cumulative % drug release was  increased  from  98% – 
99.15%.  But  as  proportion  of  PEG  6000  increased 
beyond  1  part,  for  1  part  of  CP,  cumulative  %  drug 
release decreased to about 94%. The highest dissolution 
rate is observed when both CP and PEG are present in 
the same proportion. 
The dissimilarity in dissolution profile of CP and that of 
PM as well as solid dispersions A-E was indicated by f2 
value  [less  than  50]  as  shown  in  Table  3.  When 
dissolution  profile  of  A  –  E  was  compared  among 
themselves  it was observed that dissolution profiles of 
A,B,C,D and E were comparable as indicated by f2 value 
[ between 50 – 100] as shown in Table 3. Dissolution 
profile of solid Dispersions A, B and C were very similar 
as shown by f2 value > 70 (Table 3)  
Model-Dependent Methods 
Linearization  of  the  CP  dissolution  profiles  using  the 
equations  in  Table  2  would  better  characterize  the 
differences found among all solid dispersions. Plots for 
various kinetic models are shown in Figures 2–6. 
Zero  order  rate  describes  the  systems  where  the  drug 
release rate is independent of its concentration. Figure 2 
shows  cumulative  amount  of  drug  release  vs  time  for 
zero order kinetics. The first order, which describes the 
release  from  the  systems  where  the  release  rate  is 
concentration  dependent,  is  illustrated  by  Figure  3, 
which shows log cumulative percent drug remaining vs 
time.  Figure  4  illustrates  Hixson  crowell’s  cube  root 
kinetics showing cube root of % Drug remaining vs time. 
Higuchi’s model shown in the Figure 5 describes release 
of the drug as a square root of time dependent process 
based on fickian diffusion. Figure 6 shows plot for the 
Korsmeyer-Peppas equation showing Log Cumulative % 
Drug Release vs log time. 
The release constant was calculated from the slope of the 
appropriate plots, and the regression coefficient (r
2) was 
determined (Table 4). It was found that in vitro release of 
all  five  solid  dispersions  A-E  was  best  explained  by 
Korsemeyer  peppas  equation  as  the  plots  showed  the 
highest  linearity  (r
2  >  0.98  for  all  solid  dispersions), 
followed by First order  and Higuchi’s model (r
2 > 0.95 
for  all  solid  dispersions).  Solid  dispersion  A  showing 
highest dissolution rate showed highest value of linearity 
for  Korsemeyer Peppas  model,  followed  by  first order 
model followed by Higuchi’s model as compared with 
remaining four solid dispersions (B, C, D, E). 
CONCLUSION  
Hence  based  on  dissolution  data,  Model  independent 
studies and model dependent studies, it can be concluded 
that Solid dispersion A containing 1:1 ratio of CP to PEG 
6000 showed highest dissolution rate. Dissolution profile 
of Solid dispersion A is comparable to B,C, D and E as 
indicated  by  similarity  factors  (  between  50  -  100  ). 
Highest linearity for dissolution profile was observed for 
Korsemeyer Peppas model, followed by first order model 
followed  by  Higuchi’s  model  for  all  solid  dispersions 
with values very close to 1 for solid dispersion A.       
ACKNOWLEDGEMENT 
Authors are thankful to Dr. A.R. Madgulkar, Principal, 
AISSMS  College  of  Pharmacy,  Pune  for  providing  all 
facilities  to  carry  out  the  work.  Authors  also  thank 
Maxim Pharmaceuticals Pvt. Ltd. Pune for providing gift 
sample of Cefpodoxime proxetil. 
REFERENCES 
1.  Todd  WM.  Cefpodoxime  Proxetil:  a  comprehensive  review. 
International Journal of Antimicrobial Agents1994; 4:37-62. 
2.  Patel  N,  Chotai  N,  Patel  J,  Soni  T,  Desai  D,  and  Patel  R. 
Comparison of In vitro Dissolution Profiles of Oxcarbazepine-
HP  b-CD  Tablet  Formulations  with  Marketed  Oxcarbazepine 
Tablets.Dissolution Technologies 2008; Nov:28-34. 
3.  Carrico  CK.  Workshop  report—AAPS:  USP  workshop  on 
dissolution calibration and testing. Pharm. Res1996; 13: 6–9. 
4.  Shah  VP,  Lesko  LJ,  Fan  J,  Fleischer  N,  Handerson  J, 
Malinowski  H, et al. FDA Guidance for Industry: Dissolution 
Testing  of  Immediate  Release  Solid  Oral  Dosage  Forms. 
Dissolution Technol1997; 4: 5–22. 
5.  Costa  P,  Lobo  JMS.  Modeling and  comparison  of  dissolution 
profiles. Eur J Pharm Sci. 2001; 13:123-133. Dhoka Madhura V et al / IJRAP 2011, 2 (2) 650-654 
International Journal of Research in Ayurveda & Pharmacy, 2(2), 2011  650-654   
6.  Sathe  PM,  Tsong  Y,  Shah  VP.  In  vitro  dissolution  profile 
comparison: Statistics and analysis, model dependent approach. 
Pharm Res1996; 13: 1799–1803. 
7.  Uksel  NY,  Kanik  AE,  Baykara  T,  Comparison  of  in  vivo 
dissolution  profiles  by  ANOVA  based,  model-  dependant  and 
independent  methods.  International  journal  of 
pharmaceutics2000; 209: 57-67.  
8.  Kakumanu  VK,  Arora  V,  Bansal  AK.  Investigation  of  factors 
responsible for low oral bioavailability of Cefpodoxime Proxetil. 
Int J Pharm2006; 12:155-165. 
9.  Kai  T.  Oral  absorption  improvement  of  poorly  soluble  drug 
using  solid  dispersion  technique.  Chem  Pharm  Bull1996;  44 
Suppl 3: 568-571. 
10. Modi A, Tayade P. Enhancement of dissolution profile by Solid 
dispersion (kneading) Technique. AAPS PharmSciTech2006; 7 
Suppl 3: E1-E6. 
11. Ketkar A, Patil V, Paradkar A. PCP Disso v2.08 software. 
 
Table 1: Solid dispersions of CP and PEG 6000 
Batch 
Code 
PD  PM  A  B  C  D  E 
CP: 
PEG  1:0  1:1  1:1  1:0.75  1:0.5  0.75:1  0.5:1 
CP : Cefpodoxime Proxetil 
 
 
 
 
 
 
Table 2: Applied Dissolution Models 
Models  Equations  Graph 
Zero order  Qt = Q0 + K0t  Cumulative % drug release 
Vs. Time 
First order  In Qt  = In Q0 + K1t 
Log cumulative % drug 
remaining Vs. Time 
Higuchi  Qt  = KHt1/2  Cumulative % drug release 
Vs. square root of time. 
Hixson- Crowell  W01/3 -  Wt1/3 =  Kst  Cube root of % drug 
remaining Vs. Time. 
Korsmeyer- 
peppas  M0/Mt = atn  Log cumulative percent 
drug released Vs log time. 
 
Qt: amount of drug released in time t, Q0: initial amount of drug in the tablet, k0, k1, 
kH, Ks: release rate constants, n: release exponent (indicative of drug release 
mechanism), m: accumulated fraction of the drug, a: scale parameter, Ti: location 
parameter 
 
Table 3:  f2 Values for Each Comparison 
 
Comparison  f2 
Dissolution 
Profile 
 
Comparison  f2 
Dissolution 
Profile 
PD × A  13.81  Dissimilar  A × B  70.31  Similar 
PD × B  13.36  Dissimilar  A × C  76.05  Similar 
PD × C  13.81  Dissimilar  A × D  50.16  Similar 
PD × D  13.55  Dissimilar  A × E  69.73   
Similar 
PD × E  14.54  Dissimilar  B × C  83.90  Similar 
PM × A  15.88  Dissimilar  B × D  48.38  Dissimilar 
PM × B  15.38  Dissimilar  B × E  73.60  Similar 
PM × C  15.59  Dissimilar  C × D  49.33  Dissimilar 
PM × D  15.59  Dissimilar  C × E  77.87  Similar 
PM × E  16.69  Dissimilar  D × E  55.18  Similar 
 
Table 4: Parameters of various dissolution models applied 
 
Dissolution 
Model  PD  PM  A  B  C  D  E 
Zero-order 
K0 
R
2 
0.6847  0.8011  2.0319  2.0315  2.0310  1.7721  1.9608 
0.9444  0.9483  0.8138  0.7376  0.7687  0.7728  0.7485 
First-order 
K0 
R
2 
-0.0083  -
0.0101  -0.0758  -0.0657  -0.0695  -0.0373  -0.0519 
0.9683  0.9975  0.9821  0.9878  0.9823  0.9521  0.9793 
Hixson–
Crowell K0 
R
2 
-0.0026 
-
0.0031  -0.0142  -0.0134  -0.0137  -0.0094  -0.0118 
0.9615  0.9693  0.9814  0.9484  0.9701  0.9036  0.9231 
Higuchi K0 
R
2 
4.6453  5.4395  14.102  14.2044  14.1638  12.3474  13.7002 
0.9895  0.9969  0.9799  0.9578  0.9686  0.9676  0.9625 
Korsmeyer 
peppas K0 
R
2 
4.7155  4.9099  29.1634  41.67  36.102  32.4566  37.5511 
0.9562  0.9919  0.9842  0.9830  0.9993  0.9737  0.9988 
R
2= Determination Coefficient, K0 = Release rate constantDhoka Madhura V et al / IJRAP 2011, 2 (2) 650-654 
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Figure 1: Mean (n = 3) in vitro dissolution profiles of solid dispersions of CP 
 
 
Figure 2: Zero-order plots for CP solid dispersions 
 
 
 
Figure 3: First-order plots for CP solid dispersions 
 
 
   
 
 
 
Figure 4: Hixson–Crowell plots CP solid dispersions 
 
 
 
Figure 5: Higuchi plots for CP solid dispersions 
 
 
 
Figure 6: Korsmeyer peppas plots for CP solid dispersions 
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